A distinct antigen presentation pathway drives potent T cell immunity in lipid nanoparticle–based mRNA vaccines
Authors:
- Ryunosuke MuroRMRyunosuke Muro
- Suqi WangSWSuqi Wang
- Taku Ito-KurehaTITaku Ito-Kureha
- Hung Hiep HuynhHHHung Hiep Huynh
- Kouji KobiyamaKKKouji Kobiyama
- Takuya SugitaTSTakuya Sugita
- Kazuo OkamotoKOKazuo Okamoto
- Kenta NakanoKNKenta Nakano
- Masato KuboMKMasato Kubo
- Ken J. IshiiKIKen J. Ishii
- Takeshi NittaTNTakeshi Nitta
Open Access
- 17 July 2026
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (29) , eaec7827
Abstract
Lipid nanoparticle–encapsulated mRNA (mRNA-LNP) vaccines trigger the potent differentiation of antigen-specific cytotoxic CD8 T cells in addition to antibody production. Despite its high immunogenicity, the cellular mechanisms by which mRNA-LNP induces such unusual immune responses remain largely unclear. Here, we show that mRNA-LNP induces potent and long-lasting CD8 T cell expansion through an antigen presentation mechanism that differs from that of conventional adjuvants. In mice immunized with mRNA-LNP, the number of antigen-specific CD8 T cells was one order of magnitude higher than that induced by combining antigen proteins with immunostimulants such as lipopolysaccharide or polyinosinic:polycytidinic acid. Intramuscularly administered mRNA-LNPs were mainly taken up by migratory type 2 conventional dendritic cells in draining lymph nodes, resulting in notably strong and persistent antigen presentation through major histocompatibility complex class I. Furthermore, CD8 T cell induction by mRNA-LNP required migratory dendritic cells but not the traditional cross-presentation pathway that is otherwise essential for antiviral and antitumor immunity. Thus, the mRNA-LNP formulation exerts unconventional immune responses through a different antigen-presentation pathway from conventional component vaccines.Keywords
Funding Information
- Takeda Science Foundation
- Takeda Science Foundation
- Nakatomi Foundation
- Uehara Memorial Foundation (202410010)
- Japan Agency for Medical Research and Development (JP223fa627001)
- Japan Agency for Medical Research and Development (JP19gm1210008)
- Japan Agency for Medical Research and Development (JP23ek0410108)
- Cancer Research Institute, Kanazawa University
- Japan Agency for Medical Research and Development (JP223fa627006)
- Japan Society for the Promotion of Science (25K02511)
- UTOPIA Young Researcher Development Program (JP223fa627001)
- Astellas Foundation for Research on Metabolic Disorders
- NOVARTIS Foundation (Japan) for the Promotion of Science
- Japan Society for the Promotion of Science (25H01872)
- Japan Society for the Promotion of Science (24K22044)
- Japan Society for the Promotion of Science (23H04770)
- Japan Society for the Promotion of Science (22H02886)
- Astellas Foundation for Research on Metabolic Disorders
- Japan Society for the Promotion of Science (22K07114)
- TUS research grant
- Pharmacodynamics Research Foundation
- Hamaguchi Foundation for the Advancement of Biochemistry
- Kowa Life Science Foundation
- Hamaguchi Foundation for the Advancement of Biochemistry
- Kowa Life Science Foundation
- Secom Science and Technology Foundation
- Japan Society for the Promotion of Science (21H05046)
This publication has 41 references indexed in Scilit:
- Distinct components of mRNA vaccines cooperate to instruct efficient germinal center responsesCell, 2025
- Post-vaccination IgG4 and IgG2 class switch associates with increased risk of SARS-CoV-2 infectionsJournal of Infection, 2025
- Innate immune mechanisms of mRNA vaccinesImmunity, 2022
- Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responsesImmunity, 2022
- Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2Biomedicine & Pharmacotherapy, 2021
- Retroviral Gene Transduction into T Cell Progenitors for Analysis of T Cell Development in the Thymus2020
- Functions of Murine Dendritic CellsImmunity, 2016
- Re-examining class-I presentation and the DRiP hypothesisTrends in Immunology, 2014
- Localization, Quantitation, and In Situ Detection of Specific Peptide–MHC Class I Complexes Using a Monoclonal AntibodyImmunity, 1997
- The immune responses in CD40-deficient mice: Impaired immunoglobulin class switching and germinal center formationImmunity, 1994